PUMA BIOTECHNOLOGY INC's ticker is PBYI and the CUSIP is 74587V107. A total of 176 filers reported holding PUMA BIOTECHNOLOGY INC in Q2 2018. The put-call ratio across all filers is 0.99 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2019 | $1,552,000 | +31.2% | 40,000 | +100.0% | 0.57% | +25.7% |
| Q2 2018 | $1,183,000 | -30.5% | 20,000 | -20.0% | 0.46% | -42.7% |
| Q1 2018 | $1,701,000 | -50.8% | 25,000 | -28.6% | 0.79% | -38.2% |
| Q4 2017 | $3,460,000 | +44.5% | 35,000 | +75.0% | 1.28% | +57.5% |
| Q3 2017 | $2,395,000 | +37.0% | 20,000 | 0.0% | 0.82% | +27.3% |
| Q2 2017 | $1,748,000 | +56.6% | 20,000 | -33.3% | 0.64% | +23.1% |
| Q1 2017 | $1,116,000 | +21.2% | 30,000 | 0.0% | 0.52% | +18.5% |
| Q4 2016 | $921,000 | – | 30,000 | – | 0.44% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| EcoR1 Capital, LLC | 2,536,156 | $21,405,000 | 2.24% |
| Palo Alto Investors LP | 1,396,163 | $11,784,000 | 0.99% |
| Camber Capital Management LP | 1,950,000 | $16,458,000 | 0.98% |
| TANG CAPITAL MANAGEMENT LLC | 800,000 | $6,752,000 | 0.95% |
| Capital Impact Advisors, LLC | 147,303 | $1,243,000 | 0.52% |
| Sofinnova Investments, Inc. | 638,026 | $5,385,000 | 0.50% |
| DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 963,212 | $8,130,000 | 0.26% |
| RICE HALL JAMES & ASSOCIATES, LLC | 466,482 | $3,937,000 | 0.22% |
| PDT Partners, LLC | 204,238 | $1,724,000 | 0.14% |
| Eversept Partners, LP | 58,251 | $491,638 | 0.12% |